Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating cancer by administering tumor necrosis factor receptor ligand superfamily (TNFRSF) single-chain polypeptides

Method of treating cancer by administering tumor necrosis factor receptor ligand superfamily (TNFRSF) single-chain polypeptides

US Patent 10232017 · Granted Mar 19, 2019

Estimated economic value: $677,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

VEGF/DLL4 binding agents and uses thereof2022
Combination therapy for treatment of disease2021
VEGF/DLL4 binding agents and uses thereof2020
TIGIT-binding agents and uses thereof2020
Tight-binding agents and uses thereof2018
Antibodies directed to IL-17A/IL-17F heterodimers2018
Method for making heteromultimeric molecules2018
Modified immunoglobulin molecules that specifically bind human VEGF and DLL42018
Methods for identifying and isolating cells expressing a polypeptide2018
Compositions and methods for diagnosing and treating cancer2017
Immunotherapy with binding agents2017
Methods of treating cancer by administering a soluble receptor comprising a huma2017